Influenza Vaccines Global Market Report 2025

Influenza Vaccines Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on influenza vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for influenza vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The influenza vaccines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Vaccine Type: Inactivated; Live Attenuated

2) By Valency: Quadrivalent; Trivalent

3) By Route Of Administration: Injection; Nasal Spray

4) By Age Group: Pediatric; Adult

5) By Distribution Channel: Hospitals And Pharmacies; Government And Institutional Supply; Other Distribution Channels

Subsegments:

1) By Inactivated: Trivalent Inactivated Vaccines (TIV); Quadrivalent Inactivated Vaccines (QIV)

2) By Live Attenuated: Live Attenuated Influenza Vaccines (LAIV); Quadrivalent Live Attenuated Influenza Vaccines (QLAIV)

Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Novartis AG; Sanofi-Aventis LLC.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Executive Summary
2. Influenza Vaccines Market Characteristics
3. Influenza Vaccines Market Trends And Strategies
4. Influenza Vaccines Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market
5. Global Influenza Vaccines Growth Analysis And Strategic Analysis Framework
5.1. Global Influenza Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Influenza Vaccines Market Growth Rate Analysis
5.4. Global Influenza Vaccines Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Influenza Vaccines Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Influenza Vaccines Total Addressable Market (TAM)
6. Influenza Vaccines Market Segmentation
6.1. Global Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Inactivated
Live Attenuated
6.2. Global Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Quadrivalent
Trivalent
6.3. Global Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Injection
Nasal Spray
6.4. Global Influenza Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pediatric
Adult
6.5. Global Influenza Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals and Pharmacies
Government and Institutional Supply
Other Distribution Channels
6.6. Global Influenza Vaccines Market, Sub-Segmentation Of Inactivated, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Trivalent Inactivated Vaccines (TIV)
Quadrivalent Inactivated Vaccines (QIV)
6.7. Global Influenza Vaccines Market, Sub-Segmentation Of Live Attenuated, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Live Attenuated Influenza Vaccines (LAIV)
Quadrivalent Live Attenuated Influenza Vaccines (QLAIV)
7. Influenza Vaccines Market Regional And Country Analysis
7.1. Global Influenza Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Influenza Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Influenza Vaccines Market
8.1. Asia-Pacific Influenza Vaccines Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Influenza Vaccines Market
9.1. China Influenza Vaccines Market Overview
9.2. China Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Influenza Vaccines Market
10.1. India Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Influenza Vaccines Market
11.1. Japan Influenza Vaccines Market Overview
11.2. Japan Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Influenza Vaccines Market
12.1. Australia Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Influenza Vaccines Market
13.1. Indonesia Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Influenza Vaccines Market
14.1. South Korea Influenza Vaccines Market Overview
14.2. South Korea Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Influenza Vaccines Market
15.1. Western Europe Influenza Vaccines Market Overview
15.2. Western Europe Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Influenza Vaccines Market
16.1. UK Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Influenza Vaccines Market
17.1. Germany Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Influenza Vaccines Market
18.1. France Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Influenza Vaccines Market
19.1. Italy Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Influenza Vaccines Market
20.1. Spain Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Influenza Vaccines Market
21.1. Eastern Europe Influenza Vaccines Market Overview
21.2. Eastern Europe Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Influenza Vaccines Market
22.1. Russia Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Influenza Vaccines Market
23.1. North America Influenza Vaccines Market Overview
23.2. North America Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Influenza Vaccines Market
24.1. USA Influenza Vaccines Market Overview
24.2. USA Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Influenza Vaccines Market
25.1. Canada Influenza Vaccines Market Overview
25.2. Canada Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Influenza Vaccines Market
26.1. South America Influenza Vaccines Market Overview
26.2. South America Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Influenza Vaccines Market
27.1. Brazil Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Influenza Vaccines Market
28.1. Middle East Influenza Vaccines Market Overview
28.2. Middle East Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Influenza Vaccines Market
29.1. Africa Influenza Vaccines Market Overview
29.2. Africa Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Influenza Vaccines Market Competitive Landscape And Company Profiles
30.1. Influenza Vaccines Market Competitive Landscape
30.2. Influenza Vaccines Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Sanofi-Aventis LLC. Overview, Products and Services, Strategy and Financial Analysis
31. Influenza Vaccines Market Other Major And Innovative Companies
31.1. AstraZeneca PLC
31.2. GlaxoSmithKline plc.
31.3. Serum Institute of India Private Limited
31.4. Takeda Pharmaceutical Company Limited
31.5. Moderna Inc.
31.6. Viatris Inc.
31.7. CSL Limited
31.8. Seqirus Inc.
31.9. Daiichi Sankyo Company Limited
31.10. China National Pharmaceutical Group Corporation
31.11. Shanghai Fosun Pharmaceutical Group Co. Ltd.
31.12. Mitsubishi Tanabe Pharma Corporation
31.13. Shionogi & Co. Ltd.
31.14. Liaoning Cheng Da Biotechnology Co. Ltd.
31.15. Novavax AB
32. Global Influenza Vaccines Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Influenza Vaccines Market
34. Recent Developments In The Influenza Vaccines Market
35. Influenza Vaccines Market High Potential Countries, Segments and Strategies
35.1 Influenza Vaccines Market In 2029 - Countries Offering Most New Opportunities
35.2 Influenza Vaccines Market In 2029 - Segments Offering Most New Opportunities
35.3 Influenza Vaccines Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings